Drug Repurposing AI Agents
pathoscribeai.com

Find new indications for existing drugs — in weeks, not years.

PathoscribeAI is an agentic AI platform that screens approved and shelved compounds against your target disease and returns an evidence-backed candidate report.

The Problem

Drug development takes a decade and billions of dollars, and most promising repurposing opportunities are buried across disconnected datasets that no single team can search by hand.

Our Solution

Our repurposing agent assembles disease biology, scores existing drugs for mechanistic fit, filters on safety, and hands back a ranked, cited shortlist — reviewed by our scientists.

Proof Point

Performance is reported against held-out ground truth on public datasets — repurposing back-tested on repoDB and ChEMBL, and ADMET/toxicity scored on the open Therapeutics Data Commons (TDC) leaderboard tasks. We share the full evaluation protocol so partners can reproduce every figure.

What a Pilot Delivers

Ranked shortlist (~5 candidates) for one target disease
Mechanistic rationale + supporting evidence per candidate
Known safety / ADMET flags
Written report + walkthrough call

Pricing & Timeline

₹50,000

Fixed fee per single-target pilot · 2–3 weeks kickoff to report · creditable toward a larger engagement.